HC Wainwright Boosts Sana Biotechnology (NASDAQ:SANA) Price …

Jan 8, 2025 · Sana Biotechnology (NASDAQ:SANA - Get Free Report) had its price objective lifted by HC Wainwright from $8.00 to $11.00 in a report released on Wednesday,Benzinga …

$8.00
OFF

HC Wainwright Boosts Sana Biotechnology (NASDAQ:SANA) Price …

2 weeks from now

Jan 8, 2025 · Sana Biotechnology (NASDAQ:SANA - Get Free Report) had its price objective lifted by HC Wainwright from $8.00 to $11.00 in a report released on Wednesday,Benzinga …

marketbeat.com

$11
OFF

H.C. Wainwright Ups Sana Target After ‘best Case Scenario’ Data

2 weeks from now

Jan 8, 2025 · H.C. Wainwright raised the firm’s price target on Sana Biotechnology (SANA) to $11 from $8 and keeps a Buy rating on the shares. The firm increased its probability of sucess for …

nasdaq.com

$8.00
OFF

Sana Biotechnology (NASDAQ:SANA) Upgraded To "Buy" At TD …

2 weeks from now

Jan 8, 2025 · HC Wainwright reaffirmed a "buy" rating and set a $8.00 price target on shares of Sana Biotechnology in a research report on Wednesday, November 27th. ... Shares of …

marketbeat.com

$11
OFF

Buy Reiterated For Sana Stock After Phase 1 Data Supports Unique …

2 weeks from now

Jan 8, 2025 · On Tuesday, H.C. Wainwright analyst Emily Bodnar increased the price target for Sana Biotechnology (NASDAQ:SANA) shares to $11 from the previous $8, while maintaining a …

investing.com

$8.00
OFF

Analyst Keeps Buy On Sana Biotechnology, Adjusts Outlook As …

2 weeks from now

Nov 11, 2024 · In other recent news, Sana Biotechnology has maintained its Buy rating and $8.00 price target from H.C. Wainwright, following the announcement of its third-quarter 2024 …

investing.com

$2.78
OFF

HC Wainwright Reaffirms “Buy” Rating For Sana Biotechnology …

2 weeks from now

Nov 30, 2024 · NASDAQ SANA opened at $2.78 on Wednesday. The firm has a market cap of $620.69 million, a price-to-earnings ratio of -1.99 and a beta of 1.44. The business has a 50 …

etfdailynews.com

400%
OFF

Citi Keeps $15 Target On Sana, Says Data ... - Markets Insider

2 weeks from now

Jan 8, 2025 · Read More on SANA: H.C. Wainwright ups Sana target after ‘best case scenario’ data; Sana Biotechnology (NASDAQ:SANA) Soars 400% on Breakthrough Diabetes Transplant ;

businessinsider.com

7%
OFF

Sana Biotechnology (NASDAQ:SANA) Trading Up 5.7% - MarketBeat

2 weeks from now

1 day ago · Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) rose 5.7% during mid-day trading on Monday . The company traded as high as $4.01 and last traded at $3.87. ... HC …

marketbeat.com

$11.00
OFF

Sana Biotechnology (SANA) Stock Price, News & Analysis

2 weeks from now

6 days ago · HC Wainwright Increases Sana Biotechnology (NASDAQ:SANA) Price Target to $11.00. January 10, 2025 | americanbankingnews.com ... Sana Biotechnology, Inc. …

marketbeat.com

$8
OFF

Sana Biotech Stock Target Cut, Buy Rating Held On Pipeline ...

2 weeks from now

Nov 5, 2024 · On Tuesday, H.C. Wainwright adjusted its outlook on shares of Sana Biotechnology (NASDAQ:SANA), reducing the price target to $8 from the previous $11 while maintaining a …

investing.com

73%
OFF

HC Wainwright Reiterates “Buy” Rating For Sana Biotechnology …

2 weeks from now

Nov 29, 2024 · HC Wainwright’s target price would suggest a potential upside of 213.73% from the company’s previous close. A number of […] Sana Biotechnology (NASDAQ:SANA – Get …

defenseworld.net

5%
OFF

Sana Biotechnology (NASDAQ:SANA) Shares Down 5.5

2 weeks from now

14 hours ago · Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report)'s share price was down 5.5% during mid-day trading on Wednesday . The stock traded as low as $3.32 and last …

marketbeat.com

$12.00
OFF

HC Wainwright Cuts Sana Biotechnology (NASDAQ:SANA) Price …

2 weeks from now

Aug 12, 2024 · Sana Biotechnology (NASDAQ:SANA – Free Report) had its price objective decreased by HC Wainwright from $12.00 to $11.00 in a research report released on Friday …

etfdailynews.com

7%
OFF

Sana Biotechnology (NASDAQ:SANA) Trading Up 5.7% - MarketBeat

2 weeks from now

3 days ago · Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report)'s stock price shot up 5.7% on Monday . The company traded as high as $4.01 and last traded at $3.87. 2,159,066 …

marketbeat.com

FAQs about HC Wainwright Boosts Sana Biotechnology (NASDAQ:SANA) Price … Coupon?

Is HC Wainwright a buy?

HC Wainwright currently has a buy rating on the stock. Other analysts also recently issued research reports about the stock. TD Cowen raised shares of Sana Biotechnology from a “hold” rating to a “buy” rating in a research note on Wednesday. ...

Is Sana biotechnology a good buy?

Sana Biotechnology has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings. Sana Biotechnology has only been the subject of 3 research reports in the past 90 days. Read more about Sana Biotechnology's stock forecast and price target. ...

What is the average price target for Sana biotechnology?

As of April 24, 2023, the average one-year price target for Sana Biotechnology is 10.20. The forecasts range from a low of 6.06 to a high of $13.65. The average price target represents an increase of 86.47% from its latest reported closing price of 5.47. See our leaderboard of companies with the largest price target upside. ...

How much did Sana biotechnology IPO cost?

Sana Biotechnology (SANA) raised $322 million in an initial public offering (IPO) on Thursday, February 4th 2021. The company issued 15,000,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan and BofA Securities served as the underwriters for the IPO. How do I buy shares of Sana Biotechnology? ...

How do I receive news & ratings for Sana biotechnology?

Receive News & Ratings for Sana Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sana Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter. ...

Who owns Sana biotechnology stock?

In the past three months, Sana Biotechnology insiders have not sold or bought any company stock. 31.10% of the stock of Sana Biotechnology is held by insiders. A high percentage of insider ownership can be a sign of company health. 88.23% of the stock of Sana Biotechnology is held by institutions. ...